난소암 | 바이오모아

CGTBiologicM.D. Anderson Cancer Centervedotin (BV) and, in Hodgki…Phase 2

Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells (Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells)

Relapsed/Refractory Myeloma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5

CGTBiologicstaleZhi YangPhase 2

Anti-HER2 CAR-T (Anti-HER2 CAR-T)

Breast Cancer; Ovarian Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 1상태 DISCONTINUED

CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia · FRα

AntibodystaleRochePhase 2

Aribulin;carboplatin;bevacizumab (Aribulin;carboplatin;bevacizumab)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#항체#면역항체+2

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Relapsed or Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicRoswell Park Cancer InstitutePhase 1

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · FRα

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

Autologous B7-H3 CAR T (Autologous B7-H3 CAR T)

Extensive-Stage Small Cell Lung Cancer; Extrapulmonary Neuroendocrine Carcinoma · FRα

CGTBiologicstaleMayo ClinicPhase 1

Autologous BAFFR-targeting CAR T Cells (Autologous BAFFR-targeting CAR T Cells)

B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia · FRα

CGTBiologicstaleLuminary TherapeuticsPhase 1

Autologous CAR-T cell therapy expressing the BAFF-ligand. (Autologous CAR-T cell therapy expressing the BAFF-ligand.)

Multiple Myeloma, Refractory; Multiple Myeloma in Relapse · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5

CGTBiologicstaleBeijing GoBroad HospitalPhase 2

Autologous CD5 CAR T-cells (Autologous CD5 CAR T-cells)

T-Cell Acute Lymphocytic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5

CGTBiologicBeijing BiotechPhase 2

Autologous CD5/CD7 dual-target CAR-T module (Autologous CD5/CD7 dual-target CAR-T module)

Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleBeijing GoBroad HospitalPhase 2

Autologous CD7 CAR T-cell (Autologous CD7 CAR T-cell)

T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5

CGTBiologicstaleRoberto ChiarlePhase 2

Autologous hALK.CAR T cells (Autologous hALK.CAR T cells)

Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

B7-H3 CAR-T (B7-H3 CAR-T)

Recurrent Glioblastoma; Refractory Glioblastoma · FRα

CGTBiologicstaleStanford UniversityPhase 1

B7-H3CART (B7-H3CART)

Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstalePeproMene Bio, Inc.Phase 1

BAFFR-CAR T cells (BAFFR-CAR T cells)

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleByondis B.V.Phase 1

BYON4413 (BYON4413)

Relapsed / Refractory AML; Relapsed / Refractory MDS · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

AntibodystaleRochePhase 2

Bevacizumab + modified FOLFIRINOX (Bevacizumab + modified FOLFIRINOX)

Mucinous Ovarian Cancer; Fallopian Tube Cancer · Mucinous Ovarian Cancer

#MucinousOvarianCancer#Antibody#Phase2#항체#면역항체+3

AntibodystaleRochePhase 2

Bevacizumab； HRS-1167 (Bevacizumab； HRS-1167)

Recurrent Ovarian Cancer · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#Antibody#Phase2#항체#면역항체+2